Table 1.
DAMP | Location of action | Receptor | Inflammatory activity | Refs |
---|---|---|---|---|
mtDNA | Endosomal | TLR9 |
|
83–85 |
Intracellular | AIM2 and other uncharacterized receptor(s) | Caspase 1 activation and cytokine secretion | 94 | |
N-formyl peptides | Extracellular | FPR1 |
|
85, 87–91 |
Mitochondrial TFAM | Extracellular (functions in combination with N-formyl peptides) | Uncharacterized | Monocyte activation and cytokine secretion | 91 |
Mitochondrial ATP | Extracellular | P2RX7 and NLRP3 inflammasome |
|
93 |
mROS | Intracellular | NLRP3 inflammasome | Caspase 1 activation and cytokine secretion | 94,97 |
AIM2, absent in melanoma 2; DAMP, damage-associated molecular pattern; FPR1, formyl-peptide receptor 1; mtDNA, mitochondrial DNA; mROS, mitochondrial reactive oxygen species; NLRP3, NOD−, LRR− and pyrin domain-containing 3; P2RX7, P2X purinoceptor 7; TFAM, mitochondrial transcription factor A; TLR9, Toll-like receptor 9.